Literature DB >> 30726696

PIONEERing the In-Hospital Initiation of Sacubitril-Valsartan.

John Jarcho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30726696     DOI： 10.1056/NEJMe1900139

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Eligibility and Usage of Sacubitril/Valsartan in Korea.

Authors:  Jin-Jin Kim; Jong-Chan Youn
Journal:  Int J Heart Fail       Date:  2019-10-29

Review 2.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

3.  Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.

Authors:  Xueling Li; Qin Zhu; Qingcheng Wang; Qinggang Zhang; Yaru Zheng; Lihong Wang; Qinyang Jin
Journal:  Cardiovasc Drugs Ther       Date:  2020-10       Impact factor: 3.727

4.  Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series.

Authors:  Sepideh Taghavi; Maryam Chenaghlou; Marzieh Mirtajaddini; Ahmad Amin; Nasim Naderi
Journal:  J Cardiovasc Thorac Res       Date:  2020-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.